TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: occurrence of major cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Distal migration of the femoral stem
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in peak thrombin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Occurence of toxicity (adverse events)
Endpoint domain: Adverse events/effects
Primary endpoint: Occurence of disease recurrence/progression
Endpoint domain: Mortality/survival
Primary endpoint: Freedom from local progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change From Baseline in Pain Visual Analog Scale Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Pain Assessment Using McGill Pain Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in general motor functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Recurrence of Ulcerative Colitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Areas of consolidation in COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Death from any cause at 28 days and 3 months
Endpoint domain: Mortality/survival
Primary endpoint: Ventilator Free Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of adherence to NiCE-UK guidelines
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent Coefficient of Fat Absorption (CFA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: high resolution molecular karyotyping analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Histologic Change in Tissue Specimen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weight (KG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: length of stay (number of days)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: number of recurrent hospitalisations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: haemoglobin (g/dl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: albumin (g/dl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: hip function score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative Percent Change in Total Lesion Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants by Category of Clinical Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment Success at 30 Day Visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of viremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of participants developing rash and/or neutropenia
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment Success Proportion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total time taken to deliver ID fIPV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immune response to ID fIPV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serious adverse events (SAE) and adverse events (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of peri operative Cetuximab
Endpoint domain: Adverse events/effects
Primary endpoint: Change in F-18 florbetapir myocardial retention index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Serum oxidative stress markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Myocardial oxidative metabolism markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Magnetic resonance imaging markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Early positron emission tomography (PET) response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Persistent Postpartum Hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cognitive learning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Objective response (OR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With an HIV-1 Viral Load <50 Copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Exercise Capacity - Endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Resting Pulmonary Vascular Resistance (PVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area Under the Concentration Time Curve (AUC 0-[Tlast])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Next-Day Function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Joint Position Error (JPE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heparanase expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to complete or partial remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endothelial Cell phenotype identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes of body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Labor pain with pethidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With at Least One Dose Limiting Toxicity (DLT) Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Longitudinal change in sleep disturbance
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Longitudinal change in sleep-related impairment
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Longitudinal change in fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Longitudinal change in life satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Longitudinal change in meaning and purpose
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Longitudinal change in psychological stress experiences
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Longitudinal change in global health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall Tumour Epidermal Growth Factor Receptor (EGFR) Mutation Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Uganda Neuropsychological Test Battery Summary Measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion seropositive
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Significant arrhythmic event
Endpoint domain: Adverse events/effects
Primary endpoint: Fractional Expired Oxygen Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: neovascularization and permeability factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Localization of epileptogenic foci
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: proportion of patients with gram-negative colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Relative change in biomarker concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ex vivo thrombogenesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Bone Turnover
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Oral Cancer-free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Cue Craving Rating
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cerebral hyperperfusion syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Passive Mechanical Properties
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of patient echos that are not interpretable
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percent of patient echos that provide an automated (AI) LVEF (left ventricular ejection fraction)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to acquire images as measured by time stamps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability of SpHb to detect CoOxHb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central aortic stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Diastolic relaxation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in global scores of Menopausal Rating Scale (MRS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Purchase of high reward foods
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: perioperative blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: perioperative insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: perioperative cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Recanalization rate of the occluded target vessel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Interstitial fibrosis/tubular atrophy (IF/TA) quantified by Banff Working Group biopsy grade(s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area-Under-the-Effect Curve of Percent Change in FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Days of Abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average Peak Craving Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication Satisfaction Questionnaire (MSQ) Score Change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in perceived occupational stress
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in diurnal cortisol slope
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Spatio-temporal parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Anxiety of Children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients Who Undergo Postoperative Catheterization for Urinary Retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incident intensive care unit admission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Blood Phe Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportions Retained in Care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Renal O2 extraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Volumetric analysis of hemifaces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of hemothoraces requiring thoracic interventions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change from Visual Analogue Pain Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from isokinetic muscle strength of the hamstring and quadriceps femoris muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage of subjects with clinical wart remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with device-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients for which activation maps can be created
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine concentration of NGAL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of bone anatomy size dimensions measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of cortical bone depiction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of cancellous bone depiction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from failure
Endpoint domain: Mortality/survival
Primary endpoint: Sensitivity of the assays
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of the assays
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General Cognitive Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Verbal Fluency and Learning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of ipilimumab
Endpoint domain: Adverse events/effects
Primary endpoint: Estimated blood loss after cesarean section
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Drain Bulb Fluid Bacterial Colonization
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With no Radiographic Progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pain VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal Function as Measured by Glomerular Filtration Rate (GFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of Blood Monocytes Expressing Surface Marker CD16
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Levels of Plasma Inflammatory Marker MCP-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Blood Monocytes Expressing Surface Marker CD163
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Blood Monocytes Expressing Surface Marker CCR2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Levels of Plasma Inflammatory Marker sCD14
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement on the PROMIS Sleep Disturbance scale
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Improvement in the number of micturitions/24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Postoperative ascending cholangitis incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline Epistaxis Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of expulsions
Endpoint domain: Adverse events/effects
Primary endpoint: Use of IUD
Endpoint domain: Resource use
Primary endpoint: Difference in VAS of neck pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fibrin formation in anterior chamber
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short-term safety of autologous umbilical cord blood stem cell infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Long-term safety of autologous umbilical cord blood stem cell infusion
Endpoint domain: Adverse events/effects
Primary endpoint: 2-hour PPG Increment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: improvement in tinnitus intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate in reaching a level of minimum proficiency
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: DLT incidence
Endpoint domain: Adverse events/effects
Primary endpoint: AE and SAE incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Dose interruptions, reductions and dose intensity, by treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Adherence to the wound management system
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adherence to the antibiotic regimen
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Loss of follow-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Area under ROC curve of pulse pressure variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ventilation Defect Percent (VDP) of the lung
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: difference in change in mean score of attitudes towards homeless patients
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Remission Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of parents reading Arabic books to their children
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Utilization rates of evidence-based stroke prevention therapy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Alveolar bone thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reclassification rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of papillomavirus chronic load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Increase in anakinra dose
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Major Adverse Cardiac, Cerebrovascular, and Renal Events (MACCRE)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in supine exercise pulmonary capillary wedge pressure (PCWP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Deviation scores (dB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Carotid artery intima medial thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: VF death
Endpoint domain: Mortality/survival
Primary endpoint: Exercise tolerance capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prostate swelling reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Echocardiographic clinical response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: attentional bias toward emotional expression faces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average neck pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in autism symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bladder Intact Event-Free Survival (BI-EFS)
Endpoint domain: Mortality/survival
Primary endpoint: Successful pregnancy outcome
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Participants Experiencing Grade 3-5 Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: COVID-19-specific health related quality of life (HRQoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: COVID-19-specific psychological distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cysteamine Absorption: Area Under the Plasma Concentration Curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Plasma Cysteamine Concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Peak Plasma Cysteamine Concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of women with genetically higher risk for breast cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Indicators of cardiovascular disease (CVD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: long-term success
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change From Baseline in Cardiovascular Autonomic Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Secondary bacterial pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: Apathy measured by Lille Apathy Rating Scale (LARS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of CCT sessions completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use